Document Detail


Demystifying triglycerides: a practical approach for the clinician.
MedLine Citation:
PMID:  16122052     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Because the landmark trials of lipid-lowering statin drugs excluded patients with very high triglyceride levels, the optimal management of hypertriglyceridemia for atherosclerosis prevention is unknown. The third report of the National Cholesterol Education Program's Adult Treatment Panel (ATP-III) provides a much-needed strategy for managing patients with high triglycerides, based on the best available evidence.
Authors:
Richard L Dunbar; Daniel J Rader
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  72     ISSN:  0891-1150     ISO Abbreviation:  Cleve Clin J Med     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-26     Completed Date:  2005-10-17     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  661-6, 670-2, 674-5 passim     Citation Subset:  IM    
Affiliation:
Cardiovascular Risk Intervention Program, University of Pennsylvania School of Medicine, Philadelphia, USA. richard.dunbar@uphs.upenn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arteriosclerosis / etiology,  prevention & control*
Clofibric Acid / therapeutic use
Fish Oils / therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hypercholesterolemia / physiopathology
Hypertriglyceridemia / drug therapy*,  physiopathology,  prevention & control*
Life Style
Lipoproteins, HDL / drug effects
Lipoproteins, LDL / drug effects
Niacin / therapeutic use
Triglycerides / adverse effects,  metabolism*
Grant Support
ID/Acronym/Agency:
T32-HL-07443-25/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Fish Oils; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Triglycerides; 59-67-6/Niacin; 882-09-7/Clofibric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel use of a threadwire saw for high sacral amputation. Technical note and description of operativ...
Next Document:  Update on Wegener granulomatosis.